NASDAQ:ALDR - Alder Biopharmaceuticals Price Target & Analyst Ratings

$9.27
-0.12 (-1.28 %)
(As of 08/22/2019 04:00 PM ET)
Today's Range
$9.1450
Now: $9.27
$9.4450
50-Day Range
$8.93
MA: $10.26
$11.73
52-Week Range
$8.65
Now: $9.27
$18.95
Volume295,557 shs
Average Volume979,148 shs
Market Capitalization$775.31 million
P/E RatioN/A
Dividend YieldN/A
Beta2.5

Analyst Ratings

Alder Biopharmaceuticals (NASDAQ:ALDR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Alder Biopharmaceuticals in the last 12 months. Their average twelve-month price target is $17.7143, suggesting that the stock has a possible upside of 91.09%. The high price target for ALDR is $21.00 and the low price target for ALDR is $14.00. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.442.582.552.54
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $17.7143$20.50$21.20$22.0909
Price Target Upside: 91.09% upside79.20% upside72.64% upside97.24% upside

Alder Biopharmaceuticals (NASDAQ:ALDR) Consensus Price Target History

Alder Biopharmaceuticals (NASDAQ:ALDR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/10/2019Credit Suisse GroupReiterated RatingNeutralMediumView Rating Details
5/28/2019Svb LeerinkInitiated CoverageOutperform ➝ OutperformHighView Rating Details
5/28/2019Leerink SwannInitiated CoverageOutperform$21.00MediumView Rating Details
5/3/2019CowenSet Price TargetBuy$18.00LowView Rating Details
5/3/2019MizuhoReiterated RatingHold$15.00HighView Rating Details
5/2/2019Cantor FitzgeraldReiterated RatingHold$14.00HighView Rating Details
3/14/2019Canaccord GenuityLower Price TargetBuy ➝ Buy$21.00 ➝ $20.00HighView Rating Details
11/6/2018Wells Fargo & CoInitiated CoverageOutperformMediumView Rating Details
9/10/2018Morgan StanleyInitiated CoverageUnderweight ➝ Underweight$19.00HighView Rating Details
8/8/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$21.00 ➝ $23.00LowView Rating Details
8/7/2018Stifel NicolausInitiated CoverageBuy$30.00LowView Rating Details
8/6/2018Piper Jaffray CompaniesInitiated CoverageOverweight$28.00LowView Rating Details
6/27/2018Needham & Company LLCInitiated CoverageBuy$28.00HighView Rating Details
4/24/2018Goldman Sachs GroupInitiated CoverageNeutral$17.00HighView Rating Details
9/14/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$17.00HighView Rating Details
(Data available from 8/22/2017 forward)
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel